Rapid report

Ezetimibe for the prevention of cardiovascular Events - Rapid report

Status
Status: Commission completed
Project no.
A18-83
Last updated

Report documents

  1. Extract of the rapid report

    Ezetimibe for the prevention of cardiovascular Events - Rapid report

    published on
    Document type
    PDF document, 132 kB, EN, not accessible
  2. Rapid Report

    Ezetimibe for the prevention of cardiovascular Events - Rapid report

    published on
    Document type
    PDF document, 1 MB, DE, not accessible

Press releases

Ezetimibe reduces the risk of heart attacks and strokes

Given in addition to statin therapy, ezetimibe has a preventive effect in patients with CHD and acute coronary syndrome

Project details

Project no.
A18-83
Commission
Commission awarded on 27.11.2018 by the Federal Joint Committee (GBA).
Report type
Rapid report
Status
Commission completed
Department/Division
Drug Assessment
Topic
Digestion, metabolism and hormones
Note

The present version 2.0 of 3 September 2019 replaces version 1.0 of the rapid report of 28 June 2019. There have been changes in the risk of bias for the outcome “serious cardiovascular events”.

Contact

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form